2012, Manufacturing, Physicals and Provider

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2012

Manufacturing

Physicals

Provider

Wave of Warning Letters to Foreign OTC Drug Manufacturing Facilities Following Remote Records Requests

FDA Law Blog

AUGUST 10, 2023

Cato — On August 3rd, FDA issued 11 warning letters to foreign facilities registered as OTC drug manufacturers. Section 704(a)(4) was added to the FDCA by the Food and Drug Administration Safety and Innovation Action (FDASIA) in July 2012. By McKenzie E.

Manufacturing

Manufacturing Electronics IT Physicals

Gabapentinoids – Gabapentin and Pregabalin: Tasce Bongiovanni, Donovan Maust and Nisha Iyer

GeriPal

MARCH 2, 2023

Eric: Any other interesting tidbits or facts that we should know as providers about gabapentin or Lyrica dosing or pharmacology? And for that reason, there was actually an enormous lawsuit, and the manufacturer was fined, now I think 20 years ago, in the millions and millions of dollars for off-label prescribing.

Patient-Centered

Patient-Centered IT Healthcare Medical

Primary Care Digest

Wave of Warning Letters to Foreign OTC Drug Manufacturing Facilities Following Remote Records Requests

Gabapentinoids – Gabapentin and Pregabalin: Tasce Bongiovanni, Donovan Maust and Nisha Iyer

Stay Connected